A Study of JNJ-70033093 and Digoxin in Healthy Participants

NCT04206488 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: JNJ-70033093
DRUG: Digoxin

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]